文献速递痛风与晶体性关节病

痛风可实现缓解:NOR-Gout 研究 5 年随访结果

Remission in gout is possible: 5-year follow-up in the NOR-Gout study.
PubMed 文献 · Semin Arthritis Rheum · 2025-02-27

NOR-Gout 观察性达标治疗队列纳入 211 例晶体证实的痛风患者,接受 1 年强化达标治疗并在 1、2、5 年随访,比较三种缓解定义的表现。三种定义的缓解率均随随访升高,以简化定义最高(5 年 58.6%),且均能区分 SF-36 心理/躯体成分与 DECT 结构损伤。

要点

  • 三种缓解定义的缓解率均随时间升高,所有定义 p<0.001。
  • 5 年时简化定义缓解率 58.6%,高于初步定义 42.8% 与改良初步定义 44.1%。
  • 三种定义均能区分 SF-36 心理或躯体成分及 DECT 结构损伤。

核心结论

  • 降尿酸治疗后痛风缓解在 1 年时少见、5 年时较高,以简化定义最高;三种缓解定义对生活质量和结构改变均显示同时效度。

研究设计与样本

  • 观察性达标治疗队列,纳入晶体证实的痛风且血清尿酸升高并处于痛风发作的患者,接受 1 年强化达标治疗干预,随访至 5 年。
  • 共分析 211 例患者,平均年龄 56.4 岁,男性占 95.3%,随访点为 1、2、5 年。

主要发现

  • 初步定义在 1、2、5 年的缓解率分别为 4.6%、22.1%、42.8%。
  • 改良初步定义(对痛风所致疼痛和患者总体疾病活动度采用更宽松阈值)在 1、2、5 年的缓解率分别为 5.1%、28.4%、44.1%。
  • 简化定义(不含患者报告结局)在 1、2、5 年的缓解率分别为 7.7%、45.4%、58.6%,所有定义随时间变化 p<0.001。
  • 第 2 年和第 5 年,简化定义识别出的缓解患者多于初步定义和改良初步定义。
  • 三种定义均能区分 SF-36 心理成分(MCS)、躯体成分(PCS)或 DECT 结构损伤。

关键数值与推荐

  • 初步定义:2016 年痛风缓解初步定义。
  • 改良初步定义:对痛风所致疼痛和患者总体疾病活动度采用更宽松阈值的改良初步定义。
  • 简化定义:不含患者报告结局的简化定义。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the performance of remission definitions for gout in an observational treat-to-target patient cohort with 5 years of follow-up. METHODS: Inclusion criteria were crystal proven gout with increased serum urate levels and a flare. Remission was determined according to the 2016 preliminary gout remission definition, a modified preliminary definition with more lenient thresholds for the individual variables pain due to gout and patient global assessment of gout disease activity, and the simplified definition without patient reported outcomes. Linear mixed models were used to compare quality of life with SF-36 physical (PCS) and mental (MCS) components and structural damage with semiquantitative dual energy tomography (DECT) across patients fulfilling and not fulfilling each remission definition. RESULTS: Data were analysed from 211 patients (mean age 56.4 years, 95.3 % males) included in an intensive one-year treat-to-target intervention with follow-up at 1, 2, and 5 years. The frequency of remission increased for both the preliminary definition at 1, 2 and 5 years (4.6 %, 22.1 %, and 42.8 %), the modified preliminary definition (5.1 %, 28.4 %, and 44.1. %) and the simplified definition (7.7 %, 45.4 %, and 58.6 %)(p < 0.001 for all definitions). The simplified definition identified more patients in remission than the preliminary and the modified preliminary definition at years 2 and 5. All three definitions discriminated for SF-36 MCS, PCS or DECT. CONCLUSION: Remission in gout after urate lowering therapy was seldom after 1 but high after 5 years and was highest for the simplified definition. Remission definitions showed concurrent validity for quality of life and structural changes.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Uhlig T, Stjärne J, Karoliussen LF, et al. Remission in gout is possible: 5-year follow-up in the NOR-Gout study. Semin Arthritis Rheum. 2025. PMID: 40056480. doi:10.1016/j.semarthrit.2025.152698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。